Meiwu Technology Co Ltd

Aktienanalyse zu Meiwu Technology Co Ltd (WNW)

$2.440

-0.068 (-2.79%)Zum Schluss

Loading chart…
High
2.520
Open
2.520
VWAP
2.47
Vol
96.25K
Mkt Cap
2.59M
Low
2.440
Amount
237.41K
EV/EBITDA, TTM
0.00

Meiwu Technology Co Ltd is a holding company primarily engaged in functional skincare business. The Company operating through three segments. The Skincare Products & Service segment focuses on functional skincare formula development, skincare training services, and sales of skincare products. The Quality Food Products Platform segment primarily sells meal replacement drinks, compressed candies, and other food products to customers through an online platform. The Technical Services division mainly provides technical solutions to clients. The Company primarily operates in the domestic market.

AI analysis of Meiwu Technology Co Ltd (WNW)

hold

Meiwu Technology Co Ltd (WNW) is not a strong buy right now due to its significant decline in value over the past year, with a staggering 98.40% drop. Although there was a recent 14.34% increase over the last five days, the stock is still trading at a low price of $2.79, which is concerning given its forward P/E ratio of 0 and negative earnings metrics. The recent announcement of a 1-for-100 reverse stock split indicates attempts to stabilize the stock price, but the market's reaction has been negative, as seen with a 4.44% drop post-announcement. The main risk is the company's ongoing financial instability, highlighted by a price-to-sales ratio of 12.31 and a price-to-free cash flow of -17.34, which suggests that the company is not generating positive cash flow. Therefore, while there may be potential for recovery, the current indicators suggest holding rather than buying.

Bewertungskennzahlen

The current forward P/E ratio for Meiwu Technology Co Ltd (WNW) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio AI Price Scenarios for WNW

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%WNW

$1.96

Szenariopreis

B

Base

Base · 50%WNW

$1.68

Szenariopreis

B

Bear

Bear · 25%WNW

$1.58

Szenariopreis

Event-Zeitleiste

2026-04-17 (ET)

13:00:00

Meiwu Technology Company Ltd Trading Halted, Volatility Trading Pause

2026-04-01 (ET)

09:00:00

Meiwu Technology Announces 1-for-100 Reverse Stock Split

2026-03-16 (ET)

09:30:00

Meiwu Technology Launches Strategic AI Insights Initiative

2025-12-12 (ET)

16:20:00

Meiwu Technology Company Files $200M Mixed Securities Shelf

2025-06-17 (ET)

08:32:20

Meiwu Technology enters agreement with Shenzhen Zhinuo Weichuang

News

WNW FAQ — answered by Alphio AI

Meiwu Technology Co Ltd is a holding company primarily engaged in functional skincare business. The Company operating through three segments. The Skincare Products & Service segment focuses on functional skincare formula development, skincare training services, and sales of skincare products. The Quality Food Products Platform segment primarily sells meal replacement drinks, compressed candies, and other food products to customers through an online platform. The Technical Services division mainly provides technical solutions to clients. The Company primarily operates in the domestic market. It operates in the Consumer Cyclicals sector (CATALOG AND MAIL- ORDER HOUSES industry).

Meiwu Technology Co Ltd (WNW) is not a strong buy right now due to its significant decline in value over the past year, with a staggering 98.40% drop. Although there was a recent 14.34% increase over the last five days, the stock is still trading at a low price of $2.79, which is concerning given its forward P/E ratio of 0 and negative earnings metrics. The recent announcement of a 1-for-100 reverse stock split indicates attempts to stabilize the stock price, but the market's reaction has been negative, as seen with a 4.44% drop post-announcement. The main risk is the company's ongoing financial instability, highlighted by a price-to-sales ratio of 12.31 and a price-to-free cash flow of -17.34, which suggests that the company is not generating positive cash flow. Therefore, while there may be potential for recovery, the current indicators suggest holding rather than buying.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten